1. Home
  2. NYAX vs LQDA Comparison

NYAX vs LQDA Comparison

Compare NYAX & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYAX
  • LQDA
  • Stock Information
  • Founded
  • NYAX 2005
  • LQDA 2004
  • Country
  • NYAX Israel
  • LQDA United States
  • Employees
  • NYAX N/A
  • LQDA N/A
  • Industry
  • NYAX
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NYAX
  • LQDA Health Care
  • Exchange
  • NYAX Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • NYAX 1.2B
  • LQDA 1.3B
  • IPO Year
  • NYAX N/A
  • LQDA 2018
  • Fundamental
  • Price
  • NYAX $36.13
  • LQDA $14.50
  • Analyst Decision
  • NYAX Buy
  • LQDA Strong Buy
  • Analyst Count
  • NYAX 6
  • LQDA 7
  • Target Price
  • NYAX $34.75
  • LQDA $26.67
  • AVG Volume (30 Days)
  • NYAX 8.9K
  • LQDA 859.7K
  • Earning Date
  • NYAX 03-04-2025
  • LQDA 05-12-2025
  • Dividend Yield
  • NYAX N/A
  • LQDA N/A
  • EPS Growth
  • NYAX N/A
  • LQDA N/A
  • EPS
  • NYAX N/A
  • LQDA N/A
  • Revenue
  • NYAX $314,013,000.00
  • LQDA $15,610,000.00
  • Revenue This Year
  • NYAX $34.41
  • LQDA N/A
  • Revenue Next Year
  • NYAX $25.58
  • LQDA $208.28
  • P/E Ratio
  • NYAX N/A
  • LQDA N/A
  • Revenue Growth
  • NYAX 33.34
  • LQDA N/A
  • 52 Week Low
  • NYAX $20.31
  • LQDA $8.26
  • 52 Week High
  • NYAX $40.70
  • LQDA $16.99
  • Technical
  • Relative Strength Index (RSI)
  • NYAX 46.20
  • LQDA 45.13
  • Support Level
  • NYAX $34.64
  • LQDA $13.50
  • Resistance Level
  • NYAX $36.74
  • LQDA $15.57
  • Average True Range (ATR)
  • NYAX 0.99
  • LQDA 0.71
  • MACD
  • NYAX -0.46
  • LQDA -0.28
  • Stochastic Oscillator
  • NYAX 30.08
  • LQDA 30.86

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform and integrated POS devices. The company address a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: